Literature DB >> 9562672

Cryptogenic sensory and sensorimotor polyneuropathies.

G I Wolfe1, R J Barohn.   

Abstract

Chronic sensory or sensorimotor polyneuropathy is a common clinical problem referred to neurologists. Even with modern diagnostic approaches, up to one-third of them will remain unclassified. Recent studies have provided insight into their clinical spectrum and course. The age of onset tends to be in the sixth to seventh decade of life. Symptoms progress slowly, and most patients present with paresthesias or pain. Cryptogenic polyneuropathies are almost exclusively axonal on clinical, electrophysiologic, and histologic grounds. Overall, the prognosis is favorable, and only a small minority of patients develop significant motor disability or physical incapacitation. Progression to a nonambulatory state essentially never occurs. Successful management should focus on rational pharmacotherapy for painful paresthesias combined with patient education and reassurance.

Entities:  

Mesh:

Year:  1998        PMID: 9562672     DOI: 10.1055/s-2008-1040866

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  4 in total

1.  Obstructive sleep apnoea: an underestimated cause of peripheral neuropathy.

Authors:  J de Seze
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-10-03       Impact factor: 10.154

2.  Retrospective chart review of duloxetine and pregabalin in the treatment of painful neuropathy.

Authors:  Manoj Mittal; Mamatha Pasnoor; Reddiah B Mummaneni; Saud Khan; April McVey; David Saperstein; Laura Herbelin; Larry Ridings; Yunxia Wang; Mazen M Dimachkie; Richard J Barohn
Journal:  Int J Neurosci       Date:  2011-06-15       Impact factor: 2.292

3.  Characteristics of patients with sensory neuropathy diagnosed with abnormal small nerve fibres on skin biopsy.

Authors:  E A De Sousa; A P Hays; R L Chin; H W Sander; T H Brannagan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-08       Impact factor: 10.154

4.  Pattern-recognition approach to neuropathy and neuronopathy.

Authors:  Richard J Barohn; Anthony A Amato
Journal:  Neurol Clin       Date:  2013-05       Impact factor: 3.806

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.